ZL
Zelira Therapeutics Limited
ZLDAF · OTC
$0.26 +0.00% (+$0.00)
1M +0.00%
Market Cap $4.73M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.17
34.6% downside
Current Price
$0.26
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ZLDAF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 7,214.30x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 92.48%
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Gross margin 122,400.00%
FCF margin 747,996.00%
Net margin 553,029.00%
Quality
57 /100
Average ROIC 183.92%
Asset turnover 0.00x
ROA 278.92%
Debt
0 /100
High Current ratio 0.11x
Int. coverage -10.61x
Debt/Equity N/A
Stability
47 /100
Moderate Beta 0.60x
Profitable years 0
Rev. volatility 15.55%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ZLDAF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Oludare Odumosu
Employees
8
Headquarters
Perth